Antimicrobial photodynamic effect of the photosensitizer riboflavin, alone and in combination with colistin, against pandrug-resistant Pseudomonas aeruginosa clinical isolates
Open Access
- 2 March 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 30 (9) , 892-898
Abstract
No abstract availableKeywords
Funding Information
- Golestan University of Medical Sciences
This publication has 57 references indexed in Scilit:
- The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An UpdateDrugs, 2021
- Polymyxins, the last-resort antibiotics: Mode of action, resistance emergence, and potential solutionsJournal of Biosciences, 2021
- Photodynamic enhancement of the activity of antibiotics used in urinary tract infectionsLasers in Medical Science, 2019
- Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patientsIntensive Care Medicine, 2013
- Photodynamic Therapy for Cancer and for Infections: What Is the Difference?Israel Journal of Chemistry, 2012
- Differential Habitat Use and Niche Partitioning by Pseudomonas Species in Human HomesMicrobial Ecology, 2011
- Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA)Graefe's Archive for Clinical and Experimental Ophthalmology, 2009
- Anti-microbial photodynamic therapy: useful in the future?Lasers in Medical Science, 2006
- Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applicationsLasers in Surgery and Medicine, 2006
- Laser and Non-laser Light Sources for Photodynamic TherapyLasers in Medical Science, 2002